Skip to content

Advantages and clinical evaluation of acupuncture combined with medicine in the treatment of ischemic stroke

Advantages and clinical evaluation of acupuncture combined with medicine in the treatment of ischemic stroke

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005720
Enrollment
Unknown
Registered
2022-03-15
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ischemic stroke

Interventions

Acupuncture group:Acupuncture
Acupuncture and medicine group:Acupuncture + Buyang Huanwu Decoction
Traditional Chinese medicine group:Buyang Huanwu Decoction

Sponsors

The First Affiliated Hospital of Hunan University of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) It meets the diagnostic criteria of traditional Chinese and Western medicine for ischemic stroke, which is acute stage and recovery stage; (2) Meet the diagnostic criteria of qi deficiency and blood stasis in traditional Chinese medicine; (3) Age: 35 ~ 80 years old; (4) Mild and moderate cerebral infarction, no mental disorder, relatively stable condition, relatively few basic diseases and relatively few basic drugs; (5) Onset time = 6 months; (6) Consent to treatment, express informed consent to this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) It does not meet the diagnostic criteria of traditional Chinese and Western medicine for ischemic stroke; (2) The course of disease is more than 6 months (3) Intracerebral hemorrhage, heart, liver, kidney and other organ failure; (4) The condition is unstable and critical, and there are relatively many basic drugs; (5) Serious cognitive impairment or mental illness, unable to cooperate with treatment; (6) Pregnant women, lactating women and pregnant women; (7) Allergic to drug ingredients; (8) Patients with hemorrhagic diseases and immune system diseases; (9) Those who cannot tolerate acupuncture; (10) Coagulation dysfunction; (11) Blood pressure = 180 / 105 mmHg.

Design outcomes

Primary

MeasureTime frame
Barthel Index (BI) rating scale;Standard scale for diagnosis and efficacy evaluation of stroke;Stroke clinical neurological deficit scale (NDS);

Countries

China

Contacts

Public ContactDeng kaiwen

The First Affiliated Hospital of Hunan University of traditional Chinese Medicine

940360299@qq.com13875974085

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026